Palo Alto, CA, United States of America

Terence D Boardman


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 511(Granted Patents)


Location History:

  • Los Altos, CA (US) (2003)
  • Palo Alto, CA (US) (2000 - 2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Terence D Boardman in Biological Macromolecule Technologies

Introduction: Terence D Boardman, based in Palo Alto, California, is an accomplished inventor with a notable portfolio comprising four patents. His work primarily focuses on advancements in the preparation and use of dispersible macromolecule compositions, which hold significant potential in therapeutic applications.

Latest Patents: Among Terence D Boardman's recent patents are groundbreaking methods for creating ultrafine powders of biological macromolecules. These patents detail a process that includes atomizing liquid solutions of the macromolecules, drying the resulting droplets, and collecting the particles produced during the drying phase. By precisely managing the steps of atomization, drying, and collection, Boardman's innovations yield ultrafine dry powder compositions that are particularly effective for pulmonary delivery in therapeutic settings.

Career Highlights: Throughout his career, Terence has worked with prominent companies in the pharmaceutical industry, including Inhale Therapeutic Systems, Inc. and Novartis Pharma AG. His efforts have spanned multiple projects aimed at enhancing drug delivery systems, showcasing his dedication to innovation in healthcare.

Collaborations: Terence has collaborated with esteemed individuals in his field, including notable coworkers Robert M. Platz and Thomas K. Brewer. These partnerships have facilitated the exchange of ideas and the development of cutting-edge technologies that contribute to the advancement of biological macromolecule applications.

Conclusion: Terence D Boardman's inventive spirit and contributions to the field of dispersible macromolecule compositions exemplify the impact of innovation in pharmaceutical technology. As he continues to explore and develop methods for improved therapeutic delivery, Boardman's work aids in the evolution of more effective treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…